Patents Assigned to FSHR THERANOSTICS SAS
  • Antibodies against the human fshr extracellular domain
    Patent number: 11851496
    Abstract: The invention relates to anti-human follicle-stimulating hormone receptor antibodies. The invention also relates to use of the anti-human follicle-stimulating hormone receptor antibodies in the treatment of cancer. The present invention also relates to a process for detecting cancerous cells and a process for diagnosis cancer. The present invention finds an application in the therapeutic and diagnostic medical technical fields.
    Type: Grant
    Filed: December 9, 2020
    Date of Patent: December 26, 2023
    Assignee: FSHR THERANOSTICS SAS
    Inventor: Nicolae Ghinea